Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Initiating Phase I/II clinical trials on patients at risk or already infected

Date added: 05 May 2020

Projects should leverage clinical trials expertise to rapidly intiate clinical trials for prevention and/or treatment for COVID-19

Amount
Not limited
Agency or Funder
National Heart, Lung, and Blood Institute
Eligibility (if available)

Must already possess an NHLBI Phase I-III clinical trial award

Foreign participation? (where known)
No
Date application deadline

Broad opportunities for research funding related to COVID-19

Date added: 23 Apr 2020

BARDA is looking to help the development of products to diagnose, prevent or treat novel coronavirus infections. (BARDA will only accept submissions related to the SARS-CoV-2 virus or the COVID-19 disease until further notice.)

Amount
Unlimited
Agency or Funder
Biomedical Advanced Research and Development Authority (BARDA)
Eligibility (if available)

Single entities or teams from private sector organizations, Government laboratories, and academic institutions.

Date application deadline

Competitive revision and administrative supplements to clinical and translational awardees

Date added: 29 Apr 2020

Additional support for current Clinical and Translational Science Award (CTSA) award recipients for digital health platforms, planning of COVID-19 trials and clinical study data.

Amount
Not limited
Agency or Funder
National Center for Advancing Translational Sciences
Eligibility (if available)

Clinical and Translational Science Award (CTSA) award recipients

Foreign participation? (where known)
No
Date application deadline

Community interventions for vulnerable and disadvantaged groups

Date added: 24 Jun 2020

Projects should address the consequences of the pandemic in NIH-designated health disparity populations and vulnerable groups.

Amount
$500,000 of yearly costs per project
Agency or Funder
National Institutes of Health
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments. Applicants' institutions with foreign components are accepted.

Foreign participation? (where known)
Yes
Date application deadline

Clinical trials for at-risk elderly people

Date added: 17 Jun 2020

Project should focus on multi-site clinical trials to address ageing-related issues such as reducing transmission, risk, morbidity, mortality, severity, or complications of COVID-19.

Amount
Not limited
Agency or Funder
National Institutes of Health and National Institute on Aging
Eligibility (if available)

Higher education institutions, nonprofits, for-profit organisations, local and federal governments, non-U.S entities, non-U.S. components of U.S. organisations

Foreign participation? (where known)
Yes
Date application deadline

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID & NIGMS
Eligibility (if available)

Existing grantholders wishing to expand the scope of their research.

Foreign participation? (where known)
Yes
Date application deadline

NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak

Date added: 23 Apr 2020

Research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).

Amount
Not limited
Agency or Funder
U.S. National Institutes of Health (NIH) - NIAID
Eligibility (if available)

Grantees currently supported by active NIH (National Institute of Allergy and Infectius Diseases) funding

Date application deadline

Emergency competitive revisions for research on SARS-CoV-2 and COVID-19

Date added: 23 Apr 2020

Competitive revisions to active grants in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeut

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility (if available)

Existing NIAID grantholders

Date application deadline

Existing calls welcome proposals to develop medical countermeasures against SARS-CoV-2/COVID-19

Date added: 23 Apr 2020

NIAID announces that a number of existing calls will particularly welcome research objectives related to pathogenicity, transmission, medical countermeasures, pre-clinical testing of vaccines and therapeutics.

Agency or Funder
National Institute of Allergy and Infectious Diseases (NIAID)
Date application deadline